Unlimit Yourself and be part of the PMI Science Journey!

What is our postdoctoral program about?

Fostering innovation and building our science to the highest standards with passionate teams of experts from different scientific and technical backgrounds are a key priority for us. We have cutting edge technology, the best facilities and state-of-the-art R&D, as well as robust scientific methodologies that makes us the leader in R&D in our industry and allows us to promote scientific excellence.

 

TEMP_Postdoc

 

This 2-year postdoctoral program will give you a unique opportunity to work on interdisciplinary and innovative research projects that have a direct impact on the development of our new RRPs. As a PMI postdoctoral fellow, you will be able to make a real impact on the development of our RRPs portfolio.

 

Based in our R&D Center in Neuchâtel, Switzerland, you will conduct your research project with the support and guidance of a mentor, who will be an expert in your field of research. You will periodically present progress of your research project to our Steering Committee. As a PMI postdoctoral fellow, you will have the opportunity to publish the outcomes of your research in leading and recognized scientific publications and be part of major research conferences.

 

Why join us?

 

We’re international - you will have the opportunity to work with colleagues from all over the world. We’re flexible - we truly believe that your work should fit you and not the other way around.

Our Flexible Work Arrangement Program allows such flexibility. We’re a certified top employer - we consider our employees to be our strongest asset, and we are developing talent throughout all levels of the organization.

We are an equal opportunity employer in an inclusive environment, part of our organization's core principles.

How to apply?

 

We are always looking for new talent from different backgrounds, such as physics, chemistry, aerosol science, epidemiology, statistics, etc. Explore our openings and apply directly via our career website, www.pmi.com/careers

After reviewing your application, selected candidates will be invited for a first interview. If successful, you will be invited to our R&D Center in Switzerland to meet members of our scientific Steering Committee.   

If you are interested in applying, visit our career website www.pmi.com/careers

 

Our Ambition

 

Providing safer alternative products for smokers, who are not willing to quit, is our focus at PMI Research & Development (R&D)1.

Our primary goal is to develop a portfolio of Reduced-Risk Products (RRPs)* - that we believe will appeal to current adult smokers, but with a a risk profile that is significantly lower than currently marketed cigarettes. In order to assess whether switching to these Reduced-Risk Products can reduce the risk of developing the diseases most strongly associated with smoking when compared with continued smoking, we have developed a comprehensive and extensive scientific assessment program. See more at: https://www.pmiscience.com

Since 2008, we have invested over USD 2 billion in fundamental research, product development, scientific substantiation and adult smoker understanding. Many of the scientific disciplines are represented by PMI scientists and engineers including biology, physics, chemistry, electronic engineering, mathematics, computational science, medicine, pharmacy and fluid mechanics. We have over 430 scientists, engineers and technicians working across our sites, many of whom have had extensive experience within the pharmaceutical industry.

Although smoking rates are declining in many countries, it is estimated that by 2020, the worldwide number of smokers will be in excess of 1 billion. Providing safer alternative products for these smokers is our focus at PMI Research & Development (R&D) where we are developing novel products  - a portfolio of Reduced-Risk Products (RRPs) -  that we believe will appeal to current adult smokers, but with a risk profile that is significantly lower than currently marketed cigarettes. In order to assess whether switching to these novel products can reduce the risk of developing the diseases most strongly associated with smoking when compared to continued smoking, we have developed a comprehensive and extensive scientific assessment program.

1Philip Morris International R&D, Philip Morris Products S.A. (part of Philip Morris International group of companies).